Uriclense 500

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

Vaccinium macrocarpon, Quantity: 500 mg (Equivalent: Vaccinium macrocarpon, Qty 25 g)

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

formulario farmacéutico:

Tablet, effervescent

Composición:

Excipient Ingredients: sodium bicarbonate; tartaric acid; citric acid; sorbitol; saccharin sodium; macrogol 6000; colloidal anhydrous silica

Vía de administración:

Oral

indicaciones terapéuticas:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support bladder health ; Traditionally used in Western herbal medicine to Helps reduce occurrence of medically diagnosed cystitis ; Maintain/support urinary tract health ; Traditionally used in Western herbal medicine to Maintain/support urinary tract health ; Maintain/support urinary tract function

Resumen del producto:

Visual Identification: ;

Estado de Autorización:

Listed

Fecha de autorización:

2020-12-07